Paliris 3 Tablet ER

उत्पाद अवलोकन

About Paliris 3 Tablet ER

Paliris 3 Tablet ER is a medication containing the active ingredient Paliperidone, classified as Atypical Antipsychotic. Paliperidone, sold under the brand name Invega among others, is an atypical antipsychotic. It is used for the treatment of schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia (1
• Used for: 1) Adults: Efficacy was established in three 6-week trials and one maintenance trial
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Paliperidone, the active ingredient in Paliris 3 Tablet ER, belongs to the Atypical Antipsychotic class. 1 INDICATIONS AND USAGE Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for Treatment of schizophrenia (1. 1) Adults: Efficacy was established in three 6-week trials and one maintenance trial. (14. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Paliris 3 Tablet ER. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Paliris 3 Tablet ER for extended periods without medical advice.